Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 78% ± 22% | |
oligodendrocyte precursor cell | 11 studies | 39% ± 14% | |
endothelial cell | 11 studies | 36% ± 8% | |
glutamatergic neuron | 9 studies | 41% ± 19% | |
GABAergic neuron | 8 studies | 38% ± 17% | |
microglial cell | 5 studies | 37% ± 24% | |
type I pneumocyte | 5 studies | 78% ± 10% | |
type II pneumocyte | 5 studies | 45% ± 9% | |
kidney loop of Henle epithelial cell | 4 studies | 54% ± 29% | |
pericyte | 4 studies | 55% ± 25% | |
cardiac muscle cell | 4 studies | 23% ± 6% | |
club cell | 4 studies | 33% ± 9% | |
neuron | 3 studies | 23% ± 1% | |
epithelial cell | 3 studies | 38% ± 28% | |
granule cell | 3 studies | 28% ± 12% | |
retina horizontal cell | 3 studies | 33% ± 4% | |
ciliated cell | 3 studies | 25% ± 9% | |
interneuron | 3 studies | 35% ± 26% | |
oligodendrocyte | 3 studies | 50% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 752.07 | 2525 / 2642 | 89% | 9.60 | 630 / 705 |
kidney | 74% | 161.97 | 66 / 89 | 4% | 0.17 | 38 / 901 |
lung | 58% | 69.29 | 336 / 578 | 20% | 0.96 | 233 / 1155 |
thymus | 36% | 40.25 | 236 / 653 | 24% | 0.65 | 147 / 605 |
adrenal gland | 11% | 14.89 | 28 / 258 | 43% | 6.40 | 100 / 230 |
blood vessel | 42% | 52.52 | 567 / 1335 | 0% | 0 | 0 / 0 |
liver | 4% | 2.95 | 10 / 226 | 33% | 1.58 | 135 / 406 |
heart | 32% | 41.96 | 276 / 861 | 0% | 0 | 0 / 0 |
ovary | 3% | 3.23 | 6 / 180 | 23% | 0.83 | 98 / 430 |
intestine | 15% | 12.45 | 143 / 966 | 6% | 0.17 | 30 / 527 |
peripheral blood | 16% | 53.15 | 147 / 929 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 15% | 0.33 | 26 / 178 |
prostate | 4% | 2.83 | 11 / 245 | 5% | 0.13 | 23 / 502 |
esophagus | 0% | 0.07 | 2 / 1445 | 9% | 0.38 | 16 / 183 |
skin | 1% | 0.69 | 17 / 1809 | 8% | 0.43 | 37 / 472 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.36 | 2 / 29 |
uterus | 0% | 0 | 0 / 170 | 7% | 0.23 | 30 / 459 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.30 | 20 / 504 |
stomach | 1% | 0.32 | 2 / 359 | 3% | 0.10 | 9 / 286 |
breast | 0% | 0 | 0 / 459 | 3% | 0.16 | 37 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.22 | 1 / 45 |
adipose | 1% | 1.07 | 13 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0016477 | Biological process | cell migration |
GO_1905475 | Biological process | regulation of protein localization to membrane |
GO_0005796 | Cellular component | Golgi lumen |
GO_0009986 | Cellular component | cell surface |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0098552 | Cellular component | side of membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | GPC5 |
Protein name | Glypican 5 Glypican-5 [Cleaved into: Secreted glypican-5] |
Synonyms | |
Description | FUNCTION: Cell surface proteoglycan that bears heparan sulfate. . |
Accessions | A0A087WX13 ENST00000377067.9 ENST00000618283.1 P78333 |